Systematic review / meta-analysis / 2016
A meta-analysis found fenugreek significantly reduced fasting blood glucose, 2-hour blood glucose, HbA1c, and total cholesterol in diabetes and prediabetes.
A meta-analysis of 10 articles (12 randomized controlled trials) evaluated the effects of fenugreek on glycemic and lipid parameters in diabetes and prediabetes. Pooled results showed fenugreek significantly reduced fasting blood glucose (MD -0.84 mmol/L; 95% CI -1.38 to -0.31; p=0.002), 2-hour postprandial glucose (MD -1.30 mmol/L; 95% CI -1.78 to -0.83; p<0.0001), HbA1c (MD -1.16; 95% CI -1.23 to -1.09; p<0.00001), and total cholesterol (MD -0.30 mmol/L; 95% CI -0.56 to -0.03; p=0.03). Changes in triglycerides, LDL-c, and HDL-c were not statistically significant or required further verification. No liver or kidney toxicity was reported, with gastrointestinal discomfort being the main side effect, though some included studies were of low quality.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- Individuals with diabetes or prediabetes across 10 articles (12 studies)
- What was measured
- Fasting blood glucose, 2h postprandial glucose, HbA1c, TG, TC, LDL-c, HDL-c, safety
THE PAPER
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis.
Gong J, Fang K, Dong H, Wang D, Hu M, Lu F. J Ethnopharmacol, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.